Specialist-level diagnostics, at the point of care.
MedStake builds agentic AI that brings expert diagnostic capability to clinics and communities without specialists — starting with cervical cancer screening.
ColpoPen
In development · entering trialsAI-assisted colposcopy on a portable runtime. Built for clinics and communities without specialist support — so a nurse can screen for cervical cancer with the confidence of a specialist.
Capture
Guided screening with real-time quality assurance across the saline, acetic acid and Lugol's iodine steps.
Analyze
A proprietary reasoning architecture cross-checks findings — where the models disagree, the highest-risk reading is surfaced.
Report
Immediate IFCPC grading, Swede scoring and biopsy guidance — generated at the point of care, in minutes.
Cervical cancer is one of the leading causes of cancer death for women in Zimbabwe and across Sub-Saharan Africa — largely because screening means a specialist most communities will never reach. ColpoPen puts that capability in the room.
Partner with usMCIR — the Medstake Clinical Intelligence Runtime
One core reasoning engine, many specialties. ColpoPen runs on MCIR — and so does everything we build next. Each new specialty inherits the same diagnostic backbone.
Colposcopy
Cervical cancer screening — ColpoPen.
Entering trialsHistology
Automated tissue-slide analysis and anomaly detection.
In developmentDermatology
Lesion triage optimised for underrepresented skin tones.
PlannedWeight & lifestyle
An MCIR-powered app guiding patients through weight loss and habit change.
PlannedAnd beyond
New specialties plug into the same reasoning core.
RoadmapBuild the diagnostic engine once. Scale it across every specialty that lacks one.
A working clinic behind the technology.
The MedStake Chisipite Clinic gives us real patients, registered doctors, and a live setting to deploy and prove what we build — starting with cervical cancer screening.
Visit the clinic →Book a demo
Working in cervical cancer screening, global health, or investing in deep-tech for emerging markets? We'd love to talk.
comms@medstake.com